|
|
Effects of apolipoprotein E isoform and amifostine on memory-related DNA double strand breaks and immediate-early gene expression |
| 1 F31 AG067629-01A1 |
|
NIA |
2021 |
|
|
Alternative Splicing of ApoER2 in Alzheimers Disease |
| 1 F31 AG069498-01A1 |
|
NIA |
2021 |
|
|
Regulation of Microglial Bioenergetics and Neuroinflammation by Kv1.3 Channels in Alzheimers Disease |
| 1 F31 AG074665-01 |
|
NIA |
2021 |
|
|
Study the Underlying Mechanisms of an Alzheimer’s-Disease-Protective ApoE Mutation |
| 1 F31 AG074690-01 |
|
NIA |
2021 |
|
|
Investigation of Dysfunctional Myelin Repair in Alzheimers Disease |
| 1 F31 AG074700-01 |
|
NIA |
2021 |
|
|
Novel Acetylated Tau Immunotherapy for Alzheimer's disease |
| 1 F32 AG072826-01 |
|
NIA |
2021 |
|
|
Linking genetic subtypes of Alzheimers disease to biological and cognitive heterogeneity |
| 1 K01 AG063805-01A1 |
|
NIA |
2021 |
|
|
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinsons Disease |
| 1 K01 AG066971-01A1 |
|
NIA |
2021 |
|
|
Multimodal investigation of tau-related vasculopathy in prodromal Alzheimers disease |
| 1 K01 AG071798-01 |
|
NIA |
2021 |
|
|
Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimers disease |
| 1 K23 AG068364-01A1 |
|
NIA |
2021 |